InvestSMART

Allegra Medical Technologies Limited (ASX: AMT) - Announcements

DELISTED - Current share price for AMT : $0.029

ASX company news and announcements for Allegra Medical Technologies Limited (AMT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Allegra Medical Technologies Limited (AMT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Allegra Medical Technologies Limited (AMT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Allegra Medical Technologies Limited (AMT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4G and Corporate Governance Statement 31 Aug 2023 5:46PM $0.060 $0.029 fallen by 51.67%
- Appendix 4E and Annual Report 31 Aug 2023 5:43PM $0.060 $0.029 fallen by 51.67%
- Results of Pro-Rata Non-Renounceable Entitlement Offer 30 Aug 2023 3:10PM $0.060 $0.029 fallen by 51.67%
- Completion of Sale of the Orthopaedic Division 28 Aug 2023 6:22PM $0.060 $0.029 fallen by 51.67%
- Results of Meeting 23 Aug 2023 9:53AM $0.060 $0.029 fallen by 51.67%
- Update - Proposed issue of securities - AMT 18 Aug 2023 11:07AM $0.060 $0.029 fallen by 51.67%
- Spinal Cage FDA Submission Update 16 Aug 2023 3:52PM $0.060 $0.029 fallen by 51.67%
- Update - Proposed issue of securities - AMT 16 Aug 2023 8:49AM $0.060 $0.029 fallen by 51.67%
- Extension of Closing Date of the Entitlement Offer 16 Aug 2023 8:46AM $0.060 $0.029 fallen by 51.67%
- Despatch of Non-Renounceable Entitlement Offer Documents 2 Aug 2023 11:03AM $0.058 $0.029 fallen by 50%
- EGM Notice of Meeting and Proxy 24 Jul 2023 6:20PM $0.059 $0.029 fallen by 50.85%
- 2023 General Meeting Letter of Access and Proxy 24 Jul 2023 6:06PM $0.059 $0.029 fallen by 50.85%
- Proposed issue of securities - AMT 19 Jul 2023 9:47AM $0.055 $0.029 fallen by 47.27%
- Notice under section 708AA of the Corporations Act 2001 19 Jul 2023 9:39AM $0.055 $0.029 fallen by 47.27%
- Letter to Option Holder 19 Jul 2023 9:29AM $0.055 $0.029 fallen by 47.27%
- Letter to Ineligible Shareholders 19 Jul 2023 9:22AM $0.055 $0.029 fallen by 47.27%
- Pro Rata Non-Renounceable Entitlement Offer Booklet 19 Jul 2023 9:13AM $0.055 $0.029 fallen by 47.27%
- Rights Issue & Update on Sale of Orthopaedic Asset 19 Jul 2023 9:06AM $0.055 $0.029 fallen by 47.27%
- Extension of Loan Agreement with RIPL 28 Jun 2023 8:30AM $0.058 $0.029 fallen by 50%
- Company Update on Sale of Orthopaedic Asset 2 May 2023 7:15PM $0.071 $0.029 fallen by 59.15%
- AMT Submits 510(k) for Spinal Cage FDA Clearance 31 Mar 2023 8:21AM $0.055 $0.029 fallen by 47.27%
- Appendix 4D and Half Year Financial Report 24 Feb 2023 12:23PM $0.055 $0.029 fallen by 47.27%
- Large Animal Study Completed Showing Positive Results 22 Feb 2023 9:23AM $0.056 $0.029 fallen by 48.21%
- Company Update Correction 2 Feb 2023 4:05PM $0.080 $0.029 fallen by 63.75%
- Company Update 2 Feb 2023 2:41PM $0.080 $0.029 fallen by 63.75%

76 - 100 of 306 results

Page 4 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.